Burak Emre Gilik

Burak Emre Gilik

Auto-generated profile, based on publicly available information

Burak Emre Gilik


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2026 in Medicina
Verified
Journal Article
Open access
PDF file
YÖYakup Özgüngör
Yakup Özgüngör
BGBurak Emre Gilik
Burak Emre Gilik
EKEMRE KARAGÖZ
EMRE KARAGÖZ
HYHİCRET YENİAY
HİCRET YENİAY
MCMensure Cakirgoz
Mensure Cakirgoz
SSSıla Seven
Sıla Seven
Background and Objectives: Procalcitonin (PCT) kinetics are increasingly used as prognostic markers in sepsis, but their interpretation is confounded by dynamic changes in renal function during acute illness. This study evaluated the prognostic value of ΔPCT for 30-day mortality in critically ill patients with either sepsis or septic shock by incorporating serial kinetic eGFR measurements and renal function-adjusted ΔPCT cut-off values based on the mean kinetic eGFR during the first 48–72 h of ICU admission. Materials and Methods: This retrospective cohort study included 106 adult ICU patients with either sepsis or septic shock. Serial procalcitonin measurements were used to calculate ΔPCT as a ratio of follow-up to baseline values, while renal function was assessed using mean kinetic eGFR over the first 72 h of ICU admission. Results: Thirty-day mortality was 43.4%. ΔPCT was a strong independent predictor of mortality across all models. At 48 h, ΔPCT2 was independently associated with 30-day mortality in the overall cohort (AUC 0.793) and demonstrated independent prognostic significance only in patients with preserved renal function (GFR ≥ 30 mL/min/1.73 m2). The optimal ΔPCT2 cut-off corresponded to a 56% reduction in procalcitonin levels. At 72 h, ΔPCT3 emerged as an independent predictor of mortality regardless of renal function. ROC analysis identified an optimal ΔPCT3 cut-off corresponding to 62% procalcitonin reduction in the overall cohort, with renal function-specific thresholds of ~50% for patients with GFR < 30 mL/min/1.73 m2 and ~73% for those with preserved renal function. The combination of APACHE II score and ΔPCT3 demonstrated the highest discriminative performance for mortality prediction (AUC 0.948). Conclusions: Procalcitonin kinetics provide clinically meaningful prognostic information in sepsis when interpreted alongside dynamic renal function. While 48 h procalcitonin kinetics offer prognostic value primarily in patients with preserved renal function, 72 h ΔPCT provides renal function-independent and superior mortality discrimination. Integrating serial kinetic eGFR measurements enables renal function-adapted ΔPCT threshold determination and may improve risk stratification in critically ill septic patients.

28 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
YÖYakup Özgüngör
Yakup Özgüngör
BGBurak Emre Gilik
Burak Emre Gilik
EKEMRE KARAGÖZ
EMRE KARAGÖZ
MCMensure Cakirgoz
Mensure Cakirgoz
Background : Non-thyroidal illness syndrome is frequent in critically ill patients, but the prognostic value of dynamic changes in thyroid function tests remains unclear. This study evaluated whether serial measurements of thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) provide additional predictive value for 30-day mortality beyond conventional severity scores in ICU patients. Methods : This single-center retrospective observational study included 74 adult patients treated for ≥72 hours in a general ICU who had TSH and FT3 measured within 24 hours of admission and again at 48–72 hours. Demographic characteristics, comorbidities, APACHE II, SOFA, modified NUTRIC (mNUTRIC) scores, and routine laboratory data (including albumin, CRP, and lactate) were recorded. The primary outcome was 30-day mortality. Between-group comparisons were performed using t-tests, Mann–Whitney U, and Chi-square tests. Variables significant in univariate analyses were entered into binary logistic regression models, and predictive performance was assessed using receiver operating characteristic (ROC) curves and the Youden index. Results: The mean age was 68.7 ± 14.7 years, and 41.9% (n = 31) of patients died within 30 days. Non-survivors had higher APACHE II, SOFA, and mNUTRIC scores and lower albumin, lymphocyte count, and second FT3 levels compared with survivors (all p ≤ 0.003). Baseline FT3 and TSH were not associated with mortality, whereas both the second FT3 measurement and the ΔT3 (second–first FT3) were strongly predictive. Second FT3 <1.63 pg/mL yielded an AUC of 0.835 (sensitivity 77%, specificity 74%), and a ΔT3 log ratio threshold of –0.09 (≈20% early FT3 decline) produced an AUC of 0.835 (sensitivity 71%, specificity 81%). The APACHE II + ΔT3 (numeric) model showed the best discrimination (AUC 0.921; sensitivity 87.1%, specificity 81.4%), outperforming APACHE II alone (AUC 0.861). Conclusions : In critically ill adults, dynamic T3 kinetics—particularly early decline in FT3 within the first 72 hours—provide substantial incremental prognostic value for 30-day mortality beyond APACHE II. Serial FT3 monitoring may help identify high-risk patients whose endocrine adaptation to critical illness is failing.

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
YÖYakup Özgüngör
Yakup Özgüngör
BGBurak Emre Gilik
Burak Emre Gilik
EKEMRE KARAGÖZ
EMRE KARAGÖZ
HYHİCRET YENİAY
HİCRET YENİAY
MCMensure Cakirgoz
Mensure Cakirgoz
SSSıla Seven
Sıla Seven

Background and Objectives: Procalcitonin (PCT) kinetics are increasingly used as prognostic markers in sepsis, but their interpretation is confounded by dynamic changes in renal function during acute illness. This study evaluated the prognostic value of ΔPCT for 30-day mortality in critically ill patients with sepsis or septic shock by incorporating serial kinetic eGFR measurements and renal function–adjusted ΔPCT cut-off values based on the mean kinetic eGFR during the first 48-72 hours of ICU admission. Materials and Methods: This retrospective cohort study included 106 adult ICU patients with sepsis or septic shock. Serial procalcitonin measurements were used to calculate ΔPCT as ratio of follow-up to baseline values, while renal function was assessed using mean kinetic eGFR over the first 72 hours of ICU admission. Results: Thirty-day mortality was 43.4%. ΔPCT was a strong independent predictor of mortality across all models. At 48 hours, ΔPCT2 was independently associated with 30-day mortality in the overall cohort (AUC 0.793) and retained independent prognostic significance only in patients with preserved renal function (GFR ≥30 mL/min/1.73 m²). The optimal ΔPCT2 cut-off corresponded to a 56% reduction in procalcitonin levels. At 72 hours, ΔPCT3 emerged as an independent predictor of mortality regardless of renal function. ROC analysis identified an optimal ΔPCT3 cut-off corresponding to 62% procalcitonin reduction in the overall cohort, with renal function–specific thresholds of ~50% for patients with GFR <30 mL/min/1.73 m² and ~73% for those with preserved renal function. The combination of APACHE II score and ΔPCT3 demonstrated the highest discriminative performance for mortality prediction (AUC 0.948). Conclusions: Procalcitonin kinetics provide clinically meaningful prognostic information in sepsis when interpreted alongside dynamic renal function. While 48-hour procalcitonin kinetics offer prognostic value primarily in patients with preserved renal function, 72-hour ΔPCT provides renal function–independent and superior mortality discrimination. Integrating serial kinetic eGFR measurements enables renal function–adapted ΔPCT threshold determination and may improve risk stratification in critically ill septic patients.


30 April 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
YÖYakup Özgüngör
Yakup Özgüngör
BGBurak Emre Gilik
Burak Emre Gilik
EKEMRE KARAGÖZ
EMRE KARAGÖZ
HYHİCRET YENİAY
HİCRET YENİAY
MCMensure Cakirgoz
Mensure Cakirgoz
SSSıla Seven
Sıla Seven
Background: Non-thyroidal illness syndrome is frequent in critically ill patients, but the prognostic value of dynamic changes in thyroid function tests remains unclear. This study evaluated whether serial measurements of thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) provide additional predictive value for 30-day mortality beyond conventional severity scores in ICU patients. Methods: This single-center retrospective observational study included 74 adult patients treated for ≥72 h in a general ICU who had TSH and FT3 measured within 24 h of admission and repeated at 48–72 h. Patients aged 18 years or above admitted to the intensive care unit were included in the study. Demographic characteristics, comorbidities, APACHE II, SOFA, modified NUTRIC (mNUTRIC) scores, and routine laboratory data (including albumin, CRP, and lactate) were recorded. The primary outcome was 30-day mortality. Between-group comparisons were performed using t-tests, Mann–Whitney U, and Chi-square tests. Variables significant in univariate analyses were entered into binary logistic regression models, and predictive performance was assessed using receiver operating characteristic (ROC) curves and the Youden index. Results: The mean age was 68.7 ± 14.7 years, and 41.9% (n = 31) of the patients died within 30 days. Non-survivors had higher APACHE II, SOFA, and mNUTRIC scores and lower albumin, lymphocyte count, and second FT3 levels compared with survivors (all p ≤ 0.003). Baseline FT3 and TSH were not associated with mortality, whereas both the subsequent FT3 measurements and the ΔT3 (variance in former to latter FT3) were remarkably predictive. The latter FT3 < 1.63 pg/mL produced an AUC of 0.835 (sensitivity: 77%, specificity: 74%), and a ΔT3 log ratio threshold of −0.09 (≈20% early FT3 decline) produced an AUC of 0.835 (sensitivity: 71%, specificity: 81%). The APACHE II + ΔT3 (numeric) model showed the best discrimination (AUC: 0.921; sensitivity: 87.1%, specificity: 81.4%), outperforming APACHE II alone (AUC: 0.861). Conclusions: In critically ill adult patients, dynamic T3 kinetics—particularly premature decline in FT3 within the first 72 h—provide incremental prognostic value for 30-day mortality beyond APACHE II. Serial FT3 monitoring may help identify high-risk patients whose endocrine adaptation to critical illness is failing.

16 June 2026 in Medicina
Verified
Journal Article
Open access
PDF file
YÖYakup Özgüngör
Yakup Özgüngör
HYHİCRET YENİAY
HİCRET YENİAY
BGBurak Emre Gilik
Burak Emre Gilik
EKEMRE KARAGÖZ
EMRE KARAGÖZ
MCMensure Cakirgoz
Mensure Cakirgoz
SSSıla Seven
Sıla Seven
Background and Objectives: Tracheostomy is frequently performed in critically ill patients requiring prolonged invasive mechanical ventilation; however, factors associated with intermediate-term mortality after tracheostomy remain poorly characterized. This study aimed to identify clinical and procedural factors associated with 90-day all-cause mortality after tracheostomy in ICU patients. Materials and Methods: This retrospective multicenter cohort study included 292 adult patients who underwent tracheostomy in two tertiary ICUs between 1 October 2023 and 1 June 2025. Demographic characteristics, admission diagnoses, comorbidities, clinical severity scores, procedural variables, microbiological culture results, and survival data were collected. Univariate analyses, multivariable binary logistic regression, Cox proportional hazards regression, receiver operating characteristic (ROC) analysis, and Kaplan–Meier survival analysis were performed. Results: The overall 90-day all-cause mortality rate was 74.7%. Age, Charlson Comorbidity Index, and APACHE II score were significantly associated with 90-day mortality in univariate analyses, whereas tracheostomy timing and technique were not. In multivariable logistic regression analysis, the Charlson Comorbidity Index and APACHE II score were independently associated with mortality. Cox proportional hazards regression confirmed that both APACHE II score and Charlson Comorbidity Index were independently associated with mortality over time. ROC analysis demonstrated moderate discriminative performance for age, Charlson Comorbidity Index, and APACHE II score. Conclusions: In critically ill patients undergoing tracheostomy, 90-day mortality was high and was driven primarily by acute illness severity and comorbidity burden rather than procedural characteristics. These findings support incorporating biological vulnerability, expected recovery potential, and goals-of-care discussions into tracheostomy decision-making.

3 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MYMahmut YILMAZ
Mahmut YILMAZ
MEMete Erdemir
Mete Erdemir
MOMehmet Celal Ozturk
Mehmet Celal Ozturk
RKRahime Aydin Kayali
Rahime Aydin Kayali
BGBurak Emre Gilik
Burak Emre Gilik
LYLevent Yamanel
Levent Yamanel
Background and Objectives: Pulse oximetry is essential in ICUs but may be less accurate when peripheral perfusion is impaired. Norepinephrine, the primary vasopressor for shock, may exacerbate vasoconstriction and microcirculatory alterations, increasing discrepancy between pulse oximetry saturation (SpO2) and arterial oxygen saturation (SaO2). This study aimed to evaluate whether norepinephrine dose is associated with disagreement between SpO2 and SaO2, with particular attention to measurement variability and large discrepancies. Materials and Methods: We analyzed 1050 paired SpO2–SaO2 measurements from 196 adult ICU patients receiving norepinephrine. Dose was weight-adjusted (µg/kg/min). Based on the clinically relevant thresholds defined in the 2021 Surviving Sepsis Campaign guidelines for initiating vasopressin, doses were categorized as low (≤0.25 µg/kg/min), moderate (0.25–0.50 µg/kg/min), or high (≥0.50 µg/kg/min). A large discrepancy was defined as |SpO2 − SaO2| ≥ 5%. A generalized estimating equation (GEE) model was applied to account for repeated measurements within patients. Results: Overall mean bias was 0.91 ± 3.58%. In the primary GEE analysis accounting for repeated measurements within patients, norepinephrine dose was not significantly associated with large SpO2–SaO2 discrepancies when analyzed as a continuous variable (adjusted OR 0.964, 95% CI 0.916–1.014, p = 0.158). Categorical analyses showed a non-monotonic pattern, with only the comparison between the moderate- and high-dose groups reaching statistical significance and with wide confidence intervals limiting the precision of this finding. Unadjusted descriptive analyses suggested greater measurement variability across dose ranges, which was largely attributable to within-patient clustering. ROC analysis demonstrated limited discriminatory ability for norepinephrine dose alone (AUC 0.60). Conclusions: After accounting for repeated measurements and relevant clinical covariates, norepinephrine dose did not demonstrate a consistent dose-dependent association with large SpO2–SaO2 discrepancies. Although large SpO2–SaO2 discrepancies may occur in critically ill patients receiving norepinephrine, norepinephrine infusion rate alone should not be used as a surrogate marker of pulse oximetry reliability.